Systematic review: The efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 11, 2013, Pages 1046-1056

  Wedlake, L J ^a   Shaw, C ^a   Whelan, K ^b   Andreyev, H J N ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOSE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ACUTE TOXICITY; BLADDER CANCER; CANCER RADIOTHERAPY; DIET SUPPLEMENTATION; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HIGH FIBER DIET; HUMAN; LOW CARBOHYDRATE DIET; LOW FAT DIET; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; RADIATION PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DIET, FAT-RESTRICTED; DIETARY SUPPLEMENTS; FOOD HABITS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; PELVIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84877600191     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12316     Document Type: Review

References (73)

1. Hoskin P, (Ed.) Radiotherapy in Practice. External Beam Therapy. Oxford, UK: Oxford University Press, 2006.
2. Khalid U, McGough C, Hackett C, et al,. A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int J Radiat Oncol Biol Phys 2006; 64: 1432-41.
3. Gami B, Harrington K, Blake P, et al,. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2003; 18: 987-94.
4. Olopade F, Norman A, Blake P, et al,. A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer 2005; 9: 1663-70.
5. Bergmark K, Avall-Lundquist E, Dickman P,. Patient rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 2002; 81: 443-50.
6. al Abany M, Helgason A, Cronqvist A,. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol 2002; 41: 532-42.
7. Henningsohn L, Wijkstrom H, Dickman D,. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2002; 62: 215-25.
8. Fokdal L, Hoyer M, Meldgaard P, von der Masse H,. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 2004; 72: 139-45.
9. Crook J, Esche B, Futter N,. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996; 47: 387-94.
10. Denham JD, Hauer-Jensen M,. The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 2002; 63: 129-45.
11. Hovdenak N, Fajardo LF, Hauer-Jensen M,. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1111-7.
12. Larsen A, Bjorge B, Klementsen B, et al,. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol 2007; 46: 639-50.
13. Andreyev HJN, Wotherspoon A, Denham J, Hauer-Jensen M,. Comment: defining pelvic-radiation disease for the survivorship era. Lancet Oncol 2010; 11: 310-2.
14. Sullivan MF,. Dependence of radiation diarrhoea on the presence of bile in the intestine. Nature 1962; 195: 1217-8.
15. Mulholland M, Levitt S, Song C, Potish R, Delaney J,. The role of luminal contents in radiation enteritis. Cancer 1984; 54: 2396-402.
16. Sokol A, Lipson L, Morgenstern L, Hiatt N,. Protection against lethal irradiation injury by pancreatic enzyme exclusion. Surg Forum 1967; 18: 387-9.
17. Morgenstern L, Patin C, Krohn H,. Prolongation of survival in lethally irradiated dogs. Arch Surg 1970; 101: 586-9.
18. Hauer-Jensen M, Sauer T, Berstad T,. Influence of pancreatic secretion on late radiation enteropathy in the rat. Acta Radiol Oncol 1985; 24: 555-60.
19. Wang J, Zheng H, Sung C,. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys 1999; 45: 1289-96.
20. Wang J, Zheng H, Hauer-Jensen M,. Influence of short-term octreotide administration on chronic tissue injury, transforming growth factor b (TGF-b) overexpression, and collagen accumulation in irradiated rat intestine. J Pharmacol Exp Ther 2001; 297: 35-42.
21. Bye A, Kaasa S, Ose T, Sundfor K, Trope C,. The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy. Clin Nutr 1992; 11: 147-53.
22. Stryker J, Mortel R, Hepner G,. The effect of pelvic irradiation on lactose absorption. Int J Radiat Oncol Biol Phys 1978; 4: 859-63.
23. Wedlake L, Thomas K, McGough C, Andreyev HJN,. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: an observational study. Eur J Cancer 2008; 44: 2212-7.
24. Andersson H, Bosaeus I, Nystrom C,. Bile salt malabsorption in the radiation syndrome. Acta Radiol Oncol Radiat Phys Biol 1978; 17: 312-8.
25. Chary S, Thompson D,. A clinical trial evaluating cholestyramine to prevent diarrhea in patients maintained on low-fat diets during pelvic radiation therapy. Int J Radiat Oncol Biol Phys 1984; 10: 1885-90.
26. Yeoh EK, Horowitz M, Russo A, Muecke T, Robb T, Maddox A,. Effect of pelvic irradiation on gastrointestinal function. Am J Med 1993; 95: 397-406.
27. Husebye E, Skar V, Hoverstad T, Iversen T, Melby K,. Abdominal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995; 109: 1078-89.
28. Wang CJ, Leung SW, Chen HC, et al,. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 1998; 40: 85-91.
29. Heemsbergen WD, Peeters STH, Koper PCM, Hoogeman MS, Lebesque JV,. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 2006; 66: 3-10.
30. Wedlake LJ, Thomas K, Lalji A, et al,. Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys 2010; 78: 1163-70.
31. Jadad AR, Moore RA, Carroll D, et al,. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
32. Juni P, Altman DG, Egger M,. Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-6.
33. McGough C, Baldwin C, Frost G, Andreyev HJN,. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004; 90: 2278-87.
34. Fuccio L, Guido A, Eusebi LH, et al,. Effects of probiotics for the prevention and treatment of radiation-induced diarrhoea. J Clin Gastroenterol 2009; 43: 506-13.
35. Brown M, Buchanan R, Karran S,. Clinical observations on the effects of elemental diet supplementation during irradiation. Clin Radiol 1980; 31: 19-20.
36. Capirci C, Polico C, Amichetti M, et al,. Diet prevention of radiation acute enteric toxicity: multicentric randomised study. Radiother Oncol 2000; 56 (Suppl. 1): S44.
37. McGough C, Wedlake L, Baldwin C, et al,. Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy. Aliment Pharmacol Ther 2008; 27: 1132-9.
38. Foster K, Brown M, Alberti K, et al,. The metabolic effects of abdominal irradiation in man with and without dietary therapy with an elemental diet. Clin Radiol 1980; 31: 13-7.
39. Craighead P, Young S,. Phase II study assessing the feasibility of using elemental supplements to reduce acute enteritis in patients receiving radical pelvic radiotherapy. Am J Clin Oncol 1998; 21: 573-8.
40. McArdle A, Reid E, Laplante M, Freeman C,. Prophylaxis against radiation injury. The use of elemental diet prior to and during radiotherapy for invasive bladder cancer and in early postoperative feeding following radical cystectomy and ileal conduit. Arch Surg 1986; 121: 879-85.
41. Karlson S, Kahn JM, Portman W, Simonsen E, Onk Klin G,. A randomised trial with low fat diets to improve food intake and tolerance in women receiving abdominal radiotherapy for cancer. Clin Nutr 1989; 8 (Special Suppl.): 39
42. Wedlake L, McGough C, Shaw C, et al,. Clinical Trial: efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. J Hum Nutr Diet 2012; 25: 247-59.
43. Lodge N, Evans ML, Wilkins M, Blake P, Fryatt I,. A randomised cross-over study of the efficacy of codeine phosphate versus Ispaghulahusk in patients with gynaecological cancer experiencing diarrhoea during pelvic radiotherapy. Eur J Cancer Care 1995; 4: 8-10.
44. Liu L, Glicksman A, Coachman N, Kuten A,. Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 65-71.
45. Murphy J, Stacey D, Crook J, Thompson B, Panetta D,. Testing control of radiation-induced diarrhoea with psyllium bulking agent: a pilot study. Can Oncol Nurs J 2000; 10: 96-100.
46. McNair HA, Wedlake LJ, McVey G, Thomas K, Andreyev J, Dearnaley DP,. Can diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate? Radiother Oncol 2011; 101: 471-8.
47. Weiss RG, Stryker JA,. 14C-Lactose breath tests during pelvic radiotherapy: the effect of the amount of small bowel irradiated. Radiology 1982; 142: 507-10.
48. Stryker JA, Bartholomew M,. Failure of lactose-restricted diets to prevent radiation-induced diarrhoea in patients undergoing whole pelvis irradiation. Int J Radiat Oncol Biol Phys 1986; 12: 789-92.
49. Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S,. Preservation of intestinal integrity during radiotherapy using live lactobacillus acidophilis cultures. Clin Radiol 1988; 39: 435-7.
50. Urbancsek H, Kazar T, Mezes I, Neumann K,. Results of a double-blind, randomised study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 391-6.
51. Delia P, Sansotta G, Donato V, et al,. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 13: 912-5.
52. Giralt J, Regadera JP, Verges R, et al,. Effects of probiotic lactobacillus casei DN-114 001 in the prevention of radiation-induced diarrhea: results from multicentre, randomised, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008; 71: 1213-9.
53. Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V,. Randomised controlled trial of live lactobacillus acidophilus plus bifidobacterium in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010; 5: 31.
54. Delia P, Sansotta G, Donato V, et al,. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig Liver Dis 2002; 34 (Suppl. 2): S84-6.
55. Delia P, Sansotta G, Donato V, et al,. Prevention of radiation-induced diarrhoea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastro 2002; 97: 2150-2.
56. Kaushik N, Pietraszewski M, Holst J, O'Keefe S,. Enteral feeding without pancreatic stimulation. Pancreas 2005; 31: 353-9.
57. Vu M, Van der Veek P, Frolich M, et al,. Does jejunal feeding activate exocrine pancreatic secretion? Eur J Clin Invest 1999; 29: 1053-9.
58. O'Keefe S, Lee R, Anderson F, et al,. Physiological effects of enteral and parenteral feeding on pancreatobiliary secretion in humans. Am J Physiol Gastrointest Liver Physiol 2002; 284: G27-36.
59. Department of Health. Report on Health and Social Subjects no. 41. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: HMSO, 1991.
60. Hauer-Jensen M, Wang J,. Denham J Bowel injury: current and evolving management strategies. Semin Radiat Oncol 2003; 13: 357-71.
61. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO,. Long-chain tryglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14: 229-36.
62. Boseaus I, Andersson H, Nystro C,. Effect of a low-fat diet on bile salt excretion and diarrhoea in the gastrointestinal radiation syndrome. Acta Radiol Oncol 1979; 18: 460-4.
63. Symersky T, Vu M, Frolich M, Biemond I, Masclee A,. The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging 2002; 22: 307-11.
64. Cummings JH, Mann JI, Hishida C, Vorster HH,. Dietary fibre: an agreed definition. Lancet 2009; 373: 365-6.
65. Cook SI, Selin JH,. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998; 12: 449-507.
66. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ,. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
67. Elia M, Engfer MB, Green CJ, Silk DBA,. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther 2007; 27: 120-45.
68. Suarez F, Savaiano D, Levitt MD,. A comparison of symptoms after the consumption of milk or lactose-hydrolysed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
69. Food and Agriculture Organisation of the United Nations and World Health Organisation Working Group. Guidelines for the Evaluation of Probiotics in Food. Geneva, Switzerland: FAO/WHO, 2002.
70. Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB,. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 59-275.
71. Gerritsen J, Smidt H, Rijkers G, de Vos W,. Intestinal microbiota in human health and disease; the impact or probiotics. Genes Nutr 2011; 6: 209-40.
72. National Cancer Survivorship Initiative Vision. Available at: www.ncsi.org.uk. Accessed April 2013.
73. Whelan K, Myers C,. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomised controlled trials, and nonrandomised trials. Am J Clin Nutr 2010; 91: 678-703.